Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Yin, Lihong; Bennani-Baiti, Nabila; Powell, C Thomas (2005) Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway. J Biol Chem 280:5533-41
Hedvat, Cyrus V; Teruya-Feldstein, Julie; Puig, Pere et al. (2005) Expression of p63 in diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol 13:237-42
Gregor, Polly D; Wolchok, Jedd D; Turaga, Vandana et al. (2005) Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination. Int J Cancer 116:415-21
O'Keefe, Denise S; Bacich, Dean J; Heston, Warren D W (2004) Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene. Prostate 58:200-10
Gregor, Polly D; Wolchok, Jedd D; Ferrone, Cristina R et al. (2004) CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems. Vaccine 22:1700-8
Ghosh, Arundhati; Heston, Warren D W (2003) Effect of carbohydrate moieties on the folate hydrolysis activity of the prostate specific membrane antigen. Prostate 57:140-51
Drobnjak, Marija; Melamed, Jonathan; Taneja, Samir et al. (2003) Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. Clin Cancer Res 9:2613-9
Puig, Pere; Capodieci, Paola; Drobnjak, Marija et al. (2003) p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. Clin Cancer Res 9:5642-51
Chang, Sam S; Heston, Warren D W (2002) The clinical role of prostate-specific membrane antigen (PSMA). Urol Oncol 7:7-12
Di Como, Charles J; Urist, Marshall J; Babayan, Irina et al. (2002) p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8:494-501

Showing the most recent 10 out of 50 publications